Disseminated BCGosis After Intravesical BCG Installation for Bladder Cancer
We present three patients who developed BCGosis, a rare complication following intravesical Bacillus Calmette-Guérin (BCG) treatment for bladder cancer. These cases highlight the diverse clinical manifestations, diagnostic challenges, and management strategies of this entity, emphasizing the importance of early recognition and initiation of antimycobacterial treatment.
Authors
- Joseph C. Presti (ORCID: https://orcid.org/0000-0001-9323-492X)
- Andrea Kirmaier (ORCID: https://orcid.org/0000-0001-7206-7640)
- John L. Shaia
- Tyler Martinson (ORCID: https://orcid.org/0000-0001-6750-3954)
- Jonathan E. Volk
- Bian Wu (ORCID: https://orcid.org/0000-0002-4024-4291)
- C. Bradley Hare
Institutions
- Kaiser Permanente (US)
- Kaiser Permanente San Francisco Medical Center (US)
- Colorado Permanente Medical Group (US)
Publication Details
- Journal
- Case Reports in Infectious Diseases
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/crdi/9532859
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01